litlas
Log inCreate account

J. Mark FitzGerald

Active 1991–2025

Also published as
J Mark FitzGerald
179
Papers
30,823
Citations
90
h-index
178
i10-index

Citations

Citations per year for J. Mark FitzGerald1973: 1 citations1992: 3 citations1993: 2 citations1994: 5 citations1995: 2 citations1996: 7 citations1997: 4 citations1998: 10 citations1999: 22 citations2000: 30 citations2001: 34 citations2002: 36 citations2003: 43 citations2004: 41 citations2005: 64 citations2006: 50 citations2007: 77 citations2008: 73 citations2009: 67 citations2010: 86 citations2011: 101 citations2012: 122 citations2013: 133 citations2014: 135 citations2015: 174 citations2016: 182 citations2017: 275 citations2018: 245 citations2019: 1,157 citations2020: 1,291 citations2021: 1,203 citations2022: 1,225 citations2023: 962 citations2024: 1,320 citations2025: 673 citations2026: 16 citations1974–1991: no citations, so these years are not shown

Citation sources

Countries

World map of the countries and regions citing this authorUnited States: 2,319 citing papers, 17.5% of this breakdownUnited Kingdom: 1,340 citing papers, 10.1% of this breakdownCanada: 921 citing papers, 7% of this breakdownItaly: 687 citing papers, 5.2% of this breakdownChina: 660 citing papers, 5% of this breakdownAustralia: 543 citing papers, 4.1% of this breakdownGermany: 477 citing papers, 3.6% of this breakdownNetherlands: 467 citing papers, 3.5% of this breakdownSpain: 460 citing papers, 3.5% of this breakdownFrance: 454 citing papers, 3.4% of this breakdownJapan: 375 citing papers, 2.9% of this breakdownSweden: 322 citing papers, 2.4% of this breakdown
0%17.5%Other 31.8%

Institutions

Fields

  • Medicine82.2%
  • Biochemistry, Genetics and Molecular Biology4.2%
  • Immunology and Microbiology3.8%
  • Health Professions2.7%
  • Environmental Science2.4%
  • Nursing1%
  • Other3.7%

Topics

  • Asthma and respiratory diseases18%
  • Chronic Obstructive Pulmonary Disease (COPD) Research8.1%
  • Respiratory and Cough-Related Research5.2%
  • Allergic Rhinitis and Sensitization3.8%
  • IL-33, ST2, and ILC Pathways3.6%
  • Delphi Technique in Research3.2%
  • Other58.1%

Coauthors

All papers

Open in search
  1. Dupilumab Efficacy and Safety in Moderate-to-Severe Uncontrolled Asthma

    Authors: Mario Castro, Jonathan Corren, Ian Pavord, Jorge Máspero, Sally E. Wenzel, Klaus F. Rabe, William W. Busse, Linda Ford, Lawrence Sher, J. Mark FitzGerald, Constance H. Katelaris, Yuji Tohda, Bingzhi Zhang, Heribert Staudinger, Gianluca Pirozzi, Nikhil Amin, Marcella Ruddy, Bolanle Akinlade, Asif Khan, Jingdong Chao, Renata Martincova, Neil M.H. Graham, Jennifer D. Hamilton, Brian N. Swanson, Neil Stahl, George D. Yancopoulos, Ariel Teper - New England Journal of Medicine 2018 cited by 1,929

  2. Mepolizumab Treatment in Patients with Severe Eosinophilic Asthma

    Authors: Héctor Ortega, Mark C. Liu, Ian Pavord, Guy Brusselle, J. Mark FitzGerald, Alfredo Chetta, Marc Humbert, Lynn E. Katz, Oliver N. Keene, Steven W. Yancey, Pascal Chanez - New England Journal of Medicine 2014 cited by 2,289

  3. Efficacy and safety of benralizumab for patients with severe asthma uncontrolled with high-dosage inhaled corticosteroids and long-acting β2-agonists (SIROCCO): a randomised, multicentre, placebo-controlled phase 3 trial

    Authors: Eugene R. Bleecker, J. Mark FitzGerald, Pascal Chanez, Alberto Papi, Steven F. Weinstein, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Magnus Aurivillius, Viktoría Werkström, Mitchell Goldman - The Lancet 2016 cited by 1,380

  4. Benralizumab, an anti-interleukin-5 receptor α monoclonal antibody, as add-on treatment for patients with severe, uncontrolled, eosinophilic asthma (CALIMA): a randomised, double-blind, placebo-controlled phase 3 trial

    Authors: J. Mark FitzGerald, Eugene R. Bleecker, Parameswaran Nair, Stephanie Korn, Ken Ohta, Marek Lommatzsch, Gary T. Ferguson, William W. Busse, Peter Barker, Stephanie Sproule, Geoffrey Gilmartin, Viktoría Werkström, Magnus Aurivillius, Mitchell Goldman - The Lancet 2016 cited by 1,379

  5. Risk of cardiovascular comorbidity in patients with chronic obstructive pulmonary disease: a systematic review and meta-analysis

    Authors: Wenjia Chen, Jamie M. Thomas, Mohsen Sadatsafavi, J. Mark FitzGerald - The Lancet Respiratory Medicine 2015 cited by 709

  6. Global Initiative for Asthma Strategy 2021: Executive Summary and Rationale for Key Changes

    Authors: Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy G. Brusselle, Roland Buhl, Alvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise J. Fleming, Hiromasa Inoue, Fanny W. Ko, Jerry A. Krishnan, Mark L. Levy, Jiangtao Lin, Kevin Mortimer, Paulo M. Pitrez, Aziz Sheikh, Arzu A. Yorgancioglu, Louis-Philippe Boulet - American Journal of Respiratory and Critical Care Medicine 2021 cited by 481

  7. Global Initiative for Asthma Strategy 2021. Executive Summary and Rationale for Key Changes

    Authors: Helen K. Reddel, Leonard B. Bacharier, Eric D. Bateman, Christopher E. Brightling, Guy Brusselle, Roland Buhl, Álvaro A. Cruz, Liesbeth Duijts, Jeffrey M. Drazen, J. Mark FitzGerald, Louise Fleming, Hiromasa Inoue, Fanny W.S. Ko, Jerry A. Krishnan, Mark L Levy, Jiangtao Lin, Kevin Mortimer, Paulo Márcio Pitrez, Aziz Sheikh, Arzu Yorgancıoğlu, Louis‐Philippe Boulet - Archivos de Bronconeumología 2021 cited by 540

  8. Eosinophilic and Noneosinophilic Asthma

    Authors: Liam G. Heaney, Luis Pérez de Llano, Mona Al‐Ahmad, Vibeke Backer, John Busby, Giorgio Walter Canonica, George Christoff, Borja G. Cosío, J. Mark FitzGerald, Enrico Heffler, Takashi Iwanaga, D.J. Jackson, Andrew Menzies‐Gow, Nikolaos G. Papadopoulos, Andriana Ι. Papaioannou, Paul Pfeffer, Todor A. Popov, Celeste Porsbjerg, Chin Kook Rhee, Mohsen Sadatsafavi, Yuji Tohda, Eileen Wang, Michael E. Wechsler, Marianna Alacqua, Alan Altraja, Leif Bjermer, Unnur Steina Björnsdóttir, Arnaud Bourdin, Guy Brusselle, Roland Buhl, Richard W. Costello, Mark Hew, Mariko Siyue Koh, Sverre Lehmann, Lauri Lehtimäki, Matthew Peters, Camille Taillé, Christian Taube, Trung N. Tran, James Zangrilli, Lakmini Bulathsinhala, Victoria Carter, Isha Chaudhry, Neva Eleangovan, Naeimeh Hosseini, Marjan Kerkhof, Ruth Murray, Chris Price, David Price - CHEST Journal 2021 cited by 265

  9. Artificial Intelligence/Machine Learning in Respiratory Medicine and Potential Role in Asthma and COPD Diagnosis

    Authors: Alan Kaplan, Hui Cao, J. Mark FitzGerald, Nick Iannotti, Eric Yang, Janwillem Kocks, Κonstantinos Κostikas, David Price, Helen K. Reddel, Ioanna Tsiligianni, Claus Vogelmeier, Pascal Pfister, Paul Mastoridis - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 214

  10. Effects of an Anti-TSLP Antibody on Allergen-Induced Asthmatic Responses

    Authors: Gail M. Gauvreau, Paul M. O’Byrne, Louis‐Philippe Boulet, Ying Wang, Donald W. Cockcroft, Jeannette Bigler, J Mark FitzGerald, Michael Boedigheimer, Beth E. Davis, Clapton Dias, Kevin Gorski, Lynn Smith, Edgar Bautista, Michael R. Comeau, Richard Leigh, Jane R. Parnes - New England Journal of Medicine 2014 cited by 780

  11. Predictors of enhanced response with benralizumab for patients with severe asthma: pooled analysis of the SIROCCO and CALIMA studies

    Authors: J. Mark FitzGerald, Eugene R. Bleecker, Andrew Menzies‐Gow, James Zangrilli, Ian Hirsch, Paul Metcalfe, Paul Newbold, Mitchell Goldman - The Lancet Respiratory Medicine 2017 cited by 317

  12. Onset of effect and impact on health-related quality of life, exacerbation rate, lung function, and nasal polyposis symptoms for patients with severe eosinophilic asthma treated with benralizumab (ANDHI): a randomised, controlled, phase 3b trial

    Authors: Tim Harrison, Pascal Chanez, Francesco Menzella, Giorgio Walter Canonica, Renaud Louis, Borja G. Cosío, Njira Lugogo, Arjun Mohan, Annie Burden, Lawrence McDermott, Esther García Gil, James Zangrilli, Wolfgang Pohl, Robert Voves, Maud Deschampheleire, Renaud Louis, Jean‐Benoît Martinot, Rudi Peché, Kenneth R. Chapman, Amarjit Cheema, Delbert R. Dorscheid, J. Mark FitzGerald, Rémi Gagnon, William Patrick Killorn, Ronald Olivenstein, George Philteos, Clare D. Ramsey, Julia Rolf, Brandie Walker, Ole Hilberg, Tina Skjold, Ingrid Louise Titlestad, Auli Hakulinen, Maritta Kilpeläinen, M. Ben Hayoun, Philippe Bonniaud, Arnaud Bourdin, Pascal Chanez, Frédéric de Blay, Gaëtan Deslée, Gilles Devouassoux, A. Didier, Y. Douadi, Stéphanie Fry, Gilles Garcia, Pierre‐Olivier Girodet, Christophe Leroyer, A. Magnan, Guillaume Mahay, C. Nocent, Christophe Pison, Pauline-Marie Roux, Camille Taillé, Juliana-Angelica Tiotiu, Ekkehard Beck, Margret Jandl, Christian Kaehler, Frank Käßner, Frank Koesters, Juliane Kronsbein, Thomas Schaum, Christian Schulz, Dirk Skowasch, Christian Taube, Tobias Welte, A de Roux, Bianca Beghé, Francesco Blasi, Giorgio Walter Canonica, Giovanna Elisiana Carpagnano, Cristiano Caruso, Angelo Guido Corsico, Elio Constantino, Nunzio Crimi, Piero Maestrelli, Francesco Menzella, Manlio Milanese, Alberto Papi, Girolamo Pelaia, Laura Pini, Pierachille Santus, Eleonora Savi, Nicola Scichilone, Gianenrico Senna, Giuseppe Spadaro, Adriano Vaghi, Steven Gans, Jurgen Hölters, Bas Langeveld, Willem R. Pieters, Gerald Staaks, Ilonka van Veen, Jan Willem van den Berg, Gunnar Einvik, Sverre Lehmann, Ismael Ali García, Carlos Almonacid, Irina Bobolea, Paloma Campo Mozo, Gustavo de Luiz and 127 more - The Lancet Respiratory Medicine 2020 cited by 175

  13. Baseline FeNO Independently Predicts the Dupilumab Response in Patients With Moderate-to-Severe Asthma

    Authors: Ian Pavord, Yamo Deniz, Jonathan Corren, Thomas B. Casale, J Mark FitzGerald, Kenji Izuhara, Nadia Daizadeh, Benjamin Ortiz, Robert R. Johnson, Sivan Harel, Michel Djandji, Ledia Goga, Nora Crikelair, Paul J. Rowe, William W. Busse - The Journal of Allergy and Clinical Immunology In Practice 2022 cited by 89

  14. Long-term Safety and Clinical Benefit of Mepolizumab in Patients With the Most Severe Eosinophilic Asthma: The COSMEX Study

    Authors: Sandhya Khurana, Guy Brusselle, Elisabeth H. Bel, J. Mark FitzGerald, Matthew Masoli, Stephanie Korn, Motokazu Kato, Frank C. Albers, Eric Bradford, M Gilson, Robert G. Price, Marc Humbert - Clinical Therapeutics 2019 cited by 166

  15. Inhaled anti-TSLP antibody fragment, ecleralimab, blocks responses to allergen in mild asthma

    Authors: Gail M. Gauvreau, Jens M. Hohlfeld, J. Mark FitzGerald, Louis‐Philippe Boulet, Donald W. Cockcroft, Beth E. Davis, Stephanie Korn, Oliver Kornmann, Richard Leigh, Irvin Mayers, Henrik Watz, Sarah Schmidt Grant, Monish Jain, Maciej Cabanski, Peter Pertel, Ieuan Jones, Jean Lecot, Hui Cao, Paul M. O’Byrne - European Respiratory Journal 2023 cited by 67

  16. Long-term safety and efficacy of benralizumab in patients with severe, uncontrolled asthma: 1-year results from the BORA phase 3 extension trial

    Authors: William W. Busse, Eugene R. Bleecker, J Mark FitzGerald, Gary T. Ferguson, Peter Barker, Stephanie Sproule, Richard F. Olsson, Ubaldo J. Martin, Mitchell Goldman, Anahí Yañez, Marcelo Fernández, Alberto Tolcachier, Juan Belloni, Jorge Taborda, Maria De Salvo, Jorge Máspero, Carlos Victorio, Miguel Chirino Navarta, Mónica Grilli, Pablo Alejandro Rodríguez, María Otaola, Victor Hugo Cambursano, Patricia Malamud, Ana Stok, German Arce, Osiris Roza, Fernando Scherbovsky, Pedro Carlos Elias, Maria Salazan Saez, Matthew Peters, Martin Phillips, John W. Upham, Peter G. Gibson, Francis Thien, John Aubrey Douglass, Paul Thomas, Philip G. Bardin, Dimitar Sajkov, Mark Hew, David Langton, Andreia Luisa Francisco Pez, Carlos Cézar Fritscher, Jorge Lima Hetzel, Waldo Mattos, Rafaël Stelmach, Martti Antila, Ana Luísa Godoy Fernandes, Hristo Metev, Yavor Ivanov, Aneliya Bogdanova, Ana Dancheva Markova, M Peneva, Rumyana Veselinova, Tatyana Petkova, Vanushka Petrova, E Shopova, Yuliya Ivanova, Rumyana Yotsova, Ginka Kirkova, Galina Petrova, Svetoslav Dachev, Kostadinka Sotirova, Mariyana Stoyanova, Oleg Yakov, Vanya Ilieva-Fartunova, Catherine Lemière, Michel Laviolette, William H. Yang, J Mark FitzGerald, Bonavuth Pek, William Patrick Killorn, Claude Poirier, Guy Chouinard, Lyle Melenka, Richard Leigh, Parameswaran Nair, Delbert Dorscheid, James G. Martin, Juana Pavie, Andres Rosenblut, Claudia Cartagena, Carlos Quilodran, Silvia Muñoz, Ivana Malkusova, Josef Veverka, Stanislav Holub, Jaroslav Mareš, Radovan Kozel, Daniela Kopecka, Vladimir Zindr, Pavel Cerva, Pascal Chanez, Arnaud Bourdin, Gilles Devouassoux, Camille Taillé, Frédéric de Blay, François Goupil, Christophe Leroyer, Delphine Gourcerol, T. Didi and 360 more - The Lancet Respiratory Medicine 2018 cited by 311

  17. Baseline patient factors impact on the clinical efficacy of benralizumab for severe asthma

    Authors: Eugene R. Bleecker, Michael E. Wechsler, J. Mark FitzGerald, Andrew Menzies‐Gow, Yanping Wu, Ian Hirsch, Mitchell Goldman, Paul Newbold, James Zangrilli - European Respiratory Journal 2018 cited by 247

  18. Cluster Analysis of Inflammatory Biomarker Expression in the International Severe Asthma Registry

    Authors: Eve Denton, David Price, Trung N. Tran, Giorgio Walter Canonica, Andrew Menzies‐Gow, J. Mark FitzGerald, Mohsen Sadatsafavi, Luis Pérez de Llano, George Christoff, Anna Quinton, Chin Kook Rhee, Guy Brusselle, Charlotte Suppli Ulrik, Njira Lugogo, Fiona Hore‐Lacy, Isha Chaudhry, Lakmini Bulathsinhala, Ruth Murray, Victoria Carter, Mark Hew - The Journal of Allergy and Clinical Immunology In Practice 2021 cited by 117

  19. Inhaled Combined Budesonide–Formoterol as Needed in Mild Asthma

    Authors: Paul M. O’Byrne, J. Mark FitzGerald, Eric D. Bateman, Peter J. Barnes, Nanshan Zhong, Christina Keen, Carin Jorup, Rosa Lamarca, Stefan Ivanov, Helen K. Reddel - New England Journal of Medicine 2018 cited by 637

  20. The Projected Economic and Health Burden of Uncontrolled Asthma in the United States

    Authors: Mohsen Yaghoubi, Amin Adibi, Abdollah Safari, J. Mark FitzGerald, Mohsen Sadatsafavi - American Journal of Respiratory and Critical Care Medicine 2019 cited by 319

  21. Baseline FeNO as a prognostic biomarker for subsequent severe asthma exacerbations in patients with uncontrolled, moderate-to-severe asthma receiving placebo in the LIBERTY ASTHMA QUEST study: a post-hoc analysis

    Authors: William W. Busse, Sally E. Wenzel, Thomas B. Casale, J. Mark FitzGerald, Megan S. Rice, Nadia Daizadeh, Yamo Deniz, Naimish Patel, Sivan Harel, Paul J. Rowe, Neil M.H. Graham, Thomas G. O’Riordan, Ian Pavord - The Lancet Respiratory Medicine 2021 cited by 142

  22. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

    Authors: Andrew N Menzies-Gow, Claire McBrien, Bindhu Unni, Celeste M Porsbjerg, Mona Al-Ahmad, Christopher S Ambrose, Karin Dahl Assing, Anna von Bülow, John Busby, Borja G Cosio, J Mark FitzGerald, Esther Garcia Gil, Susanne Hansen, Liam G Heaney, Mark Hew, David J Jackson, Maria Kallieri, Stelios Loukides, Njira L Lugogo, Andriana I Papaioannou, Désirée Larenas-Linnemann, Wendy C Moore, Luis A Perez-de-Llano, Linda M Rasmussen, Johannes M Schmid, Salman Siddiqui, Marianna Alacqua, Trung N Tran, Charlotte Suppli Ulrik, John W Upham, Eileen Wang, Lakmini Bulathsinhala, Victoria A Carter, Isha Chaudhry, Neva Eleangovan, Ruth B Murray, Chris A Price, David B Price - Journal of Asthma and Allergy 2022 cited by 99

  23. Sputum Microbiome Is Associated with 1-Year Mortality after Chronic Obstructive Pulmonary Disease Hospitalizations

    Authors: Fernando Sergio Leitão Filho, Nawaf Alotaibi, David Ngan, Sheena Tam, Julia Yang, Zsuzsanna Hollander, Virginia Chen, J. Mark FitzGerald, Corey Nislow, Janice M. Leung, S. F. Paul Man, Don D. Sin - American Journal of Respiratory and Critical Care Medicine 2018 cited by 135

  24. Real World Biologic Use and Switch Patterns in Severe Asthma: Data from the International Severe Asthma Registry and the US CHRONICLE Study

    Authors: Andrew Menzies‐Gow, Claire McBrien, Bindhu Unni, Celeste Porsbjerg, Mona Al‐Ahmad, Christopher S. Ambrose, Karin Dahl Assing, Anna von Bülow, John Busby, Borja G. Cosío, J. Mark FitzGerald, Esther García Gil, Susanne Hansen, Liam G. Heaney, Mark Hew, David J. Jackson, Maria Kallieri, Stelios Loukides, Njira Lugogo, Andriana Ι. Papaioannou, Désirée Larenas‐Linnemann, Wendy C. Moore, Luis Pérez de Llano, Linda Makowska Rasmussen, Johannes Martin Schmid, Salman Siddiqui, Marianna Alacqua, Trung N. Tran, Charlotte Suppli Ulrik, John W. Upham, Eileen Wang, Lakmini Bulathsinhala, Victoria Carter, Isha Chaudhry, Neva Eleangovan, Ruth Murray, Chris Price, David Price - 2022 cited by 83